61272-64-8

Upstream product

• 27894-50-4 methyl (2S)-2-amino-6-{[(benzyloxy)carbonyl]amino}hexanoate hydrochloride 
• 32689-62-6 N^α-tert-butoxycarbonylglycyl-N^ε-benzyloxycarbonyl-L-lysine methyl ester 
• 63808-85-5 Z(OMe)-Gly-Lys(Z)-OMe 

Downstream Products

• 120452-86-0 (ZOMe)-Gly-Val-Gly-Lys(Z)-NHNH₂ 
• 120452-80-4 Z(OMe)-Gly-Val-Gly-Lys(Z)-OMe 
• 120452-79-1 Z(OMe)-Val-Gly-Lys(Z)-OMe 

Relevant academic research and scientific papers

Heterovalent inhibitors targeting N-end Rule Pathway and its use

An alkali-soluble polymer resin compound of formula 1 a including N-end Rule pathway inhibitors disclosure the composition. According to type 1 and type 2 herein each compounds recognizing substrate UBR box and a ClpS box a mammal having two tolerance N-e

Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists

The present invention relates to a conjugated compound of Formula I : Q-Z-R4 wherein Q is a TLR7 and/or TLR8 agonist and Z-R4 is a TLR2 agonist, said conjugated compound being chosen among compounds of Formula II :

Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists

A conjugated compound of Formula I: Q-Z—R4 wherein Q is a TLR7 and/or TLR8 agonist and Z—R4 is a TLR2 agonist, the conjugated compound being chosen among compounds of Formula II: